Global Cellular and Gene Therapy Product Supply, Demand and Key Producers, 2023-2029

Description

The global Cellular and Gene Therapy Product market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report studies the global Cellular and Gene Therapy Product production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cellular and Gene Therapy Product, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cellular and Gene Therapy Product that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cellular and Gene Therapy Product total production and demand, 2018-2029, (K Units)
Global Cellular and Gene Therapy Product total production value, 2018-2029, (USD Million)
Global Cellular and Gene Therapy Product production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Cellular and Gene Therapy Product consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Cellular and Gene Therapy Product domestic production, consumption, key domestic manufacturers and share
Global Cellular and Gene Therapy Product production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Cellular and Gene Therapy Product production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Cellular and Gene Therapy Product production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Cellular and Gene Therapy Product market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol-Myers Squibb, New York Blood Center, Johnson & Johnson, Cleveland Cord Blood Center, Organogenesis, Duke University School of Medicine, Colorado Cord Blood Banking, MD Anderson Cancer Center and LifeSouth Community Blood Centers, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cellular and Gene Therapy Product market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Cellular and Gene Therapy Product Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Cellular and Gene Therapy Product Market, Segmentation by Type
    Cellular Immunotherapies
    Cancer Vaccines
    Autologous and Allogeneic Cells

Global Cellular and Gene Therapy Product Market, Segmentation by Application
    Blood Cancer
    Prostate Cancer
    Skin Cancer
    Other

Companies Profiled:
    Bristol-Myers Squibb
    New York Blood Center
    Johnson & Johnson
    Cleveland Cord Blood Center
    Organogenesis
    Duke University School of Medicine
    Colorado Cord Blood Banking
    MD Anderson Cancer Center
    LifeSouth Community Blood Centers
    Bloodworks Northwest
    Amgen
    Novartis Pharmaceuticals
    Castle Creek Biosciences
    Spark Therapeutics
    Vericel
    Dendreon Pharmaceuticals
    Enzyvant Therapeutics GmbH
    Mallinckrodt
    Gilead Sciences
    bluebird bio

Key Questions Answered
1. How big is the global Cellular and Gene Therapy Product market?
2. What is the demand of the global Cellular and Gene Therapy Product market?
3. What is the year over year growth of the global Cellular and Gene Therapy Product market?
4. What is the production and production value of the global Cellular and Gene Therapy Product market?
5. Who are the key producers in the global Cellular and Gene Therapy Product market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Cellular and Gene Therapy Product Introduction
    1.2 World Cellular and Gene Therapy Product Supply & Forecast
        1.2.1 World Cellular and Gene Therapy Product Production Value (2018 & 2022 & 2029)
        1.2.2 World Cellular and Gene Therapy Product Production (2018-2029)
        1.2.3 World Cellular and Gene Therapy Product Pricing Trends (2018-2029)
    1.3 World Cellular and Gene Therapy Product Production by Region (Based on Production Site)
        1.3.1 World Cellular and Gene Therapy Product Production Value by Region (2018-2029)
        1.3.2 World Cellular and Gene Therapy Product Production by Region (2018-2029)
        1.3.3 World Cellular and Gene Therapy Product Average Price by Region (2018-2029)
        1.3.4 North America Cellular and Gene Therapy Product Production (2018-2029)
        1.3.5 Europe Cellular and Gene Therapy Product Production (2018-2029)
        1.3.6 Asia-Pacific Cellular and Gene Therapy Product Production (2018-2029)
        1.3.7 Latin America Cellular and Gene Therapy Product Production (2018-2029)
        1.3.8 Middle East & Africa Cellular and Gene Therapy Product Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Cellular and Gene Therapy Product Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Cellular and Gene Therapy Product Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Cellular and Gene Therapy Product Demand (2018-2029)
    2.2 World Cellular and Gene Therapy Product Consumption by Region
        2.2.1 World Cellular and Gene Therapy Product Consumption by Region (2018-2023)
        2.2.2 World Cellular and Gene Therapy Product Consumption Forecast by Region (2024-2029)
    2.3 United States Cellular and Gene Therapy Product Consumption (2018-2029)
    2.4 China Cellular and Gene Therapy Product Consumption (2018-2029)
    2.5 Europe Cellular and Gene Therapy Product Consumption (2018-2029)
    2.6 Japan Cellular and Gene Therapy Product Consumption (2018-2029)
    2.7 South Korea Cellular and Gene Therapy Product Consumption (2018-2029)
    2.8 ASEAN Cellular and Gene Therapy Product Consumption (2018-2029)
    2.9 India Cellular and Gene Therapy Product Consumption (2018-2029)

3 World Cellular and Gene Therapy Product Manufacturers Competitive Analysis
    3.1 World Cellular and Gene Therapy Product Production Value by Manufacturer (2018-2023)
    3.2 World Cellular and Gene Therapy Product Production by Manufacturer (2018-2023)
    3.3 World Cellular and Gene Therapy Product Average Price by Manufacturer (2018-2023)
    3.4 Cellular and Gene Therapy Product Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Cellular and Gene Therapy Product Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Cellular and Gene Therapy Product in 2022
        3.5.3 Global Concentration Ratios (CR8) for Cellular and Gene Therapy Product in 2022
    3.6 Cellular and Gene Therapy Product Market: Overall Company Footprint Analysis
        3.6.1 Cellular and Gene Therapy Product Market: Region Footprint
        3.6.2 Cellular and Gene Therapy Product Market: Company Product Type Footprint
        3.6.3 Cellular and Gene Therapy Product Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Cellular and Gene Therapy Product Production Value Comparison
        4.1.1 United States VS China: Cellular and Gene Therapy Product Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Cellular and Gene Therapy Product Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Cellular and Gene Therapy Product Production Comparison
        4.2.1 United States VS China: Cellular and Gene Therapy Product Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Cellular and Gene Therapy Product Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Cellular and Gene Therapy Product Consumption Comparison
        4.3.1 United States VS China: Cellular and Gene Therapy Product Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Cellular and Gene Therapy Product Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Cellular and Gene Therapy Product Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Cellular and Gene Therapy Product Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Cellular and Gene Therapy Product Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Cellular and Gene Therapy Product Production (2018-2023)
    4.5 China Based Cellular and Gene Therapy Product Manufacturers and Market Share
        4.5.1 China Based Cellular and Gene Therapy Product Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Cellular and Gene Therapy Product Production Value (2018-2023)
        4.5.3 China Based Manufacturers Cellular and Gene Therapy Product Production (2018-2023)
    4.6 Rest of World Based Cellular and Gene Therapy Product Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Cellular and Gene Therapy Product Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Cellular and Gene Therapy Product Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Cellular and Gene Therapy Product Production (2018-2023)

5 Market Analysis by Type
    5.1 World Cellular and Gene Therapy Product Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Cellular Immunotherapies
        5.2.2 Cancer Vaccines
        5.2.3 Autologous and Allogeneic Cells
    5.3 Market Segment by Type
        5.3.1 World Cellular and Gene Therapy Product Production by Type (2018-2029)
        5.3.2 World Cellular and Gene Therapy Product Production Value by Type (2018-2029)
        5.3.3 World Cellular and Gene Therapy Product Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Cellular and Gene Therapy Product Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Blood Cancer
        6.2.2 Prostate Cancer
        6.2.3 Skin Cancer
        6.2.4 Other
    6.3 Market Segment by Application
        6.3.1 World Cellular and Gene Therapy Product Production by Application (2018-2029)
        6.3.2 World Cellular and Gene Therapy Product Production Value by Application (2018-2029)
        6.3.3 World Cellular and Gene Therapy Product Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Bristol-Myers Squibb
        7.1.1 Bristol-Myers Squibb Details
        7.1.2 Bristol-Myers Squibb Major Business
        7.1.3 Bristol-Myers Squibb Cellular and Gene Therapy Product Product and Services
        7.1.4 Bristol-Myers Squibb Cellular and Gene Therapy Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Bristol-Myers Squibb Recent Developments/Updates
        7.1.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
    7.2 New York Blood Center
        7.2.1 New York Blood Center Details
        7.2.2 New York Blood Center Major Business
        7.2.3 New York Blood Center Cellular and Gene Therapy Product Product and Services
        7.2.4 New York Blood Center Cellular and Gene Therapy Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 New York Blood Center Recent Developments/Updates
        7.2.6 New York Blood Center Competitive Strengths & Weaknesses
    7.3 Johnson & Johnson
        7.3.1 Johnson & Johnson Details
        7.3.2 Johnson & Johnson Major Business
        7.3.3 Johnson & Johnson Cellular and Gene Therapy Product Product and Services
        7.3.4 Johnson & Johnson Cellular and Gene Therapy Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Johnson & Johnson Recent Developments/Updates
        7.3.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.4 Cleveland Cord Blood Center
        7.4.1 Cleveland Cord Blood Center Details
        7.4.2 Cleveland Cord Blood Center Major Business
        7.4.3 Cleveland Cord Blood Center Cellular and Gene Therapy Product Product and Services
        7.4.4 Cleveland Cord Blood Center Cellular and Gene Therapy Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Cleveland Cord Blood Center Recent Developments/Updates
        7.4.6 Cleveland Cord Blood Center Competitive Strengths & Weaknesses
    7.5 Organogenesis
        7.5.1 Organogenesis Details
        7.5.2 Organogenesis Major Business
        7.5.3 Organogenesis Cellular and Gene Therapy Product Product and Services
        7.5.4 Organogenesis Cellular and Gene Therapy Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Organogenesis Recent Developments/Updates
        7.5.6 Organogenesis Competitive Strengths & Weaknesses
    7.6 Duke University School of Medicine
        7.6.1 Duke University School of Medicine Details
        7.6.2 Duke University School of Medicine Major Business
        7.6.3 Duke University School of Medicine Cellular and Gene Therapy Product Product and Services
        7.6.4 Duke University School of Medicine Cellular and Gene Therapy Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Duke University School of Medicine Recent Developments/Updates
        7.6.6 Duke University School of Medicine Competitive Strengths & Weaknesses
    7.7 Colorado Cord Blood Banking
        7.7.1 Colorado Cord Blood Banking Details
        7.7.2 Colorado Cord Blood Banking Major Business
        7.7.3 Colorado Cord Blood Banking Cellular and Gene Therapy Product Product and Services
        7.7.4 Colorado Cord Blood Banking Cellular and Gene Therapy Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Colorado Cord Blood Banking Recent Developments/Updates
        7.7.6 Colorado Cord Blood Banking Competitive Strengths & Weaknesses
    7.8 MD Anderson Cancer Center
        7.8.1 MD Anderson Cancer Center Details
        7.8.2 MD Anderson Cancer Center Major Business
        7.8.3 MD Anderson Cancer Center Cellular and Gene Therapy Product Product and Services
        7.8.4 MD Anderson Cancer Center Cellular and Gene Therapy Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 MD Anderson Cancer Center Recent Developments/Updates
        7.8.6 MD Anderson Cancer Center Competitive Strengths & Weaknesses
    7.9 LifeSouth Community Blood Centers
        7.9.1 LifeSouth Community Blood Centers Details
        7.9.2 LifeSouth Community Blood Centers Major Business
        7.9.3 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Product and Services
        7.9.4 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 LifeSouth Community Blood Centers Recent Developments/Updates
        7.9.6 LifeSouth Community Blood Centers Competitive Strengths & Weaknesses
    7.10 Bloodworks Northwest
        7.10.1 Bloodworks Northwest Details
        7.10.2 Bloodworks Northwest Major Business
        7.10.3 Bloodworks Northwest Cellular and Gene Therapy Product Product and Services
        7.10.4 Bloodworks Northwest Cellular and Gene Therapy Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Bloodworks Northwest Recent Developments/Updates
        7.10.6 Bloodworks Northwest Competitive Strengths & Weaknesses
    7.11 Amgen
        7.11.1 Amgen Details
        7.11.2 Amgen Major Business
        7.11.3 Amgen Cellular and Gene Therapy Product Product and Services
        7.11.4 Amgen Cellular and Gene Therapy Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Amgen Recent Developments/Updates
        7.11.6 Amgen Competitive Strengths & Weaknesses
    7.12 Novartis Pharmaceuticals
        7.12.1 Novartis Pharmaceuticals Details
        7.12.2 Novartis Pharmaceuticals Major Business
        7.12.3 Novartis Pharmaceuticals Cellular and Gene Therapy Product Product and Services
        7.12.4 Novartis Pharmaceuticals Cellular and Gene Therapy Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Novartis Pharmaceuticals Recent Developments/Updates
        7.12.6 Novartis Pharmaceuticals Competitive Strengths & Weaknesses
    7.13 Castle Creek Biosciences
        7.13.1 Castle Creek Biosciences Details
        7.13.2 Castle Creek Biosciences Major Business
        7.13.3 Castle Creek Biosciences Cellular and Gene Therapy Product Product and Services
        7.13.4 Castle Creek Biosciences Cellular and Gene Therapy Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 Castle Creek Biosciences Recent Developments/Updates
        7.13.6 Castle Creek Biosciences Competitive Strengths & Weaknesses
    7.14 Spark Therapeutics
        7.14.1 Spark Therapeutics Details
        7.14.2 Spark Therapeutics Major Business
        7.14.3 Spark Therapeutics Cellular and Gene Therapy Product Product and Services
        7.14.4 Spark Therapeutics Cellular and Gene Therapy Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.14.5 Spark Therapeutics Recent Developments/Updates
        7.14.6 Spark Therapeutics Competitive Strengths & Weaknesses
    7.15 Vericel
        7.15.1 Vericel Details
        7.15.2 Vericel Major Business
        7.15.3 Vericel Cellular and Gene Therapy Product Product and Services
        7.15.4 Vericel Cellular and Gene Therapy Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.15.5 Vericel Recent Developments/Updates
        7.15.6 Vericel Competitive Strengths & Weaknesses
    7.16 Dendreon Pharmaceuticals
        7.16.1 Dendreon Pharmaceuticals Details
        7.16.2 Dendreon Pharmaceuticals Major Business
        7.16.3 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Product and Services
        7.16.4 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.16.5 Dendreon Pharmaceuticals Recent Developments/Updates
        7.16.6 Dendreon Pharmaceuticals Competitive Strengths & Weaknesses
    7.17 Enzyvant Therapeutics GmbH
        7.17.1 Enzyvant Therapeutics GmbH Details
        7.17.2 Enzyvant Therapeutics GmbH Major Business
        7.17.3 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Product and Services
        7.17.4 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.17.5 Enzyvant Therapeutics GmbH Recent Developments/Updates
        7.17.6 Enzyvant Therapeutics GmbH Competitive Strengths & Weaknesses
    7.18 Mallinckrodt
        7.18.1 Mallinckrodt Details
        7.18.2 Mallinckrodt Major Business
        7.18.3 Mallinckrodt Cellular and Gene Therapy Product Product and Services
        7.18.4 Mallinckrodt Cellular and Gene Therapy Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.18.5 Mallinckrodt Recent Developments/Updates
        7.18.6 Mallinckrodt Competitive Strengths & Weaknesses
    7.19 Gilead Sciences
        7.19.1 Gilead Sciences Details
        7.19.2 Gilead Sciences Major Business
        7.19.3 Gilead Sciences Cellular and Gene Therapy Product Product and Services
        7.19.4 Gilead Sciences Cellular and Gene Therapy Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.19.5 Gilead Sciences Recent Developments/Updates
        7.19.6 Gilead Sciences Competitive Strengths & Weaknesses
    7.20 bluebird bio
        7.20.1 bluebird bio Details
        7.20.2 bluebird bio Major Business
        7.20.3 bluebird bio Cellular and Gene Therapy Product Product and Services
        7.20.4 bluebird bio Cellular and Gene Therapy Product Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.20.5 bluebird bio Recent Developments/Updates
        7.20.6 bluebird bio Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Cellular and Gene Therapy Product Industry Chain
    8.2 Cellular and Gene Therapy Product Upstream Analysis
        8.2.1 Cellular and Gene Therapy Product Core Raw Materials
        8.2.2 Main Manufacturers of Cellular and Gene Therapy Product Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Cellular and Gene Therapy Product Production Mode
    8.6 Cellular and Gene Therapy Product Procurement Model
    8.7 Cellular and Gene Therapy Product Industry Sales Model and Sales Channels
        8.7.1 Cellular and Gene Therapy Product Sales Model
        8.7.2 Cellular and Gene Therapy Product Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Cellular and Gene Therapy Product Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Cellular and Gene Therapy Product Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Cellular and Gene Therapy Product Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Cellular and Gene Therapy Product Production Value Market Share by Region (2018-2023)
    Table 5. World Cellular and Gene Therapy Product Production Value Market Share by Region (2024-2029)
    Table 6. World Cellular and Gene Therapy Product Production by Region (2018-2023) & (K Units)
    Table 7. World Cellular and Gene Therapy Product Production by Region (2024-2029) & (K Units)
    Table 8. World Cellular and Gene Therapy Product Production Market Share by Region (2018-2023)
    Table 9. World Cellular and Gene Therapy Product Production Market Share by Region (2024-2029)
    Table 10. World Cellular and Gene Therapy Product Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Cellular and Gene Therapy Product Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Cellular and Gene Therapy Product Major Market Trends
    Table 13. World Cellular and Gene Therapy Product Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Cellular and Gene Therapy Product Consumption by Region (2018-2023) & (K Units)
    Table 15. World Cellular and Gene Therapy Product Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Cellular and Gene Therapy Product Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Cellular and Gene Therapy Product Producers in 2022
    Table 18. World Cellular and Gene Therapy Product Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Cellular and Gene Therapy Product Producers in 2022
    Table 20. World Cellular and Gene Therapy Product Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Cellular and Gene Therapy Product Company Evaluation Quadrant
    Table 22. World Cellular and Gene Therapy Product Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Cellular and Gene Therapy Product Production Site of Key Manufacturer
    Table 24. Cellular and Gene Therapy Product Market: Company Product Type Footprint
    Table 25. Cellular and Gene Therapy Product Market: Company Product Application Footprint
    Table 26. Cellular and Gene Therapy Product Competitive Factors
    Table 27. Cellular and Gene Therapy Product New Entrant and Capacity Expansion Plans
    Table 28. Cellular and Gene Therapy Product Mergers & Acquisitions Activity
    Table 29. United States VS China Cellular and Gene Therapy Product Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Cellular and Gene Therapy Product Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Cellular and Gene Therapy Product Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Cellular and Gene Therapy Product Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Cellular and Gene Therapy Product Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Cellular and Gene Therapy Product Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Cellular and Gene Therapy Product Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Cellular and Gene Therapy Product Production Market Share (2018-2023)
    Table 37. China Based Cellular and Gene Therapy Product Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Cellular and Gene Therapy Product Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Cellular and Gene Therapy Product Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Cellular and Gene Therapy Product Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Cellular and Gene Therapy Product Production Market Share (2018-2023)
    Table 42. Rest of World Based Cellular and Gene Therapy Product Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Cellular and Gene Therapy Product Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Cellular and Gene Therapy Product Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Cellular and Gene Therapy Product Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Cellular and Gene Therapy Product Production Market Share (2018-2023)
    Table 47. World Cellular and Gene Therapy Product Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Cellular and Gene Therapy Product Production by Type (2018-2023) & (K Units)
    Table 49. World Cellular and Gene Therapy Product Production by Type (2024-2029) & (K Units)
    Table 50. World Cellular and Gene Therapy Product Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Cellular and Gene Therapy Product Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Cellular and Gene Therapy Product Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Cellular and Gene Therapy Product Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Cellular and Gene Therapy Product Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Cellular and Gene Therapy Product Production by Application (2018-2023) & (K Units)
    Table 56. World Cellular and Gene Therapy Product Production by Application (2024-2029) & (K Units)
    Table 57. World Cellular and Gene Therapy Product Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Cellular and Gene Therapy Product Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Cellular and Gene Therapy Product Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Cellular and Gene Therapy Product Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
    Table 62. Bristol-Myers Squibb Major Business
    Table 63. Bristol-Myers Squibb Cellular and Gene Therapy Product Product and Services
    Table 64. Bristol-Myers Squibb Cellular and Gene Therapy Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Bristol-Myers Squibb Recent Developments/Updates
    Table 66. Bristol-Myers Squibb Competitive Strengths & Weaknesses
    Table 67. New York Blood Center Basic Information, Manufacturing Base and Competitors
    Table 68. New York Blood Center Major Business
    Table 69. New York Blood Center Cellular and Gene Therapy Product Product and Services
    Table 70. New York Blood Center Cellular and Gene Therapy Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. New York Blood Center Recent Developments/Updates
    Table 72. New York Blood Center Competitive Strengths & Weaknesses
    Table 73. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 74. Johnson & Johnson Major Business
    Table 75. Johnson & Johnson Cellular and Gene Therapy Product Product and Services
    Table 76. Johnson & Johnson Cellular and Gene Therapy Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Johnson & Johnson Recent Developments/Updates
    Table 78. Johnson & Johnson Competitive Strengths & Weaknesses
    Table 79. Cleveland Cord Blood Center Basic Information, Manufacturing Base and Competitors
    Table 80. Cleveland Cord Blood Center Major Business
    Table 81. Cleveland Cord Blood Center Cellular and Gene Therapy Product Product and Services
    Table 82. Cleveland Cord Blood Center Cellular and Gene Therapy Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Cleveland Cord Blood Center Recent Developments/Updates
    Table 84. Cleveland Cord Blood Center Competitive Strengths & Weaknesses
    Table 85. Organogenesis Basic Information, Manufacturing Base and Competitors
    Table 86. Organogenesis Major Business
    Table 87. Organogenesis Cellular and Gene Therapy Product Product and Services
    Table 88. Organogenesis Cellular and Gene Therapy Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Organogenesis Recent Developments/Updates
    Table 90. Organogenesis Competitive Strengths & Weaknesses
    Table 91. Duke University School of Medicine Basic Information, Manufacturing Base and Competitors
    Table 92. Duke University School of Medicine Major Business
    Table 93. Duke University School of Medicine Cellular and Gene Therapy Product Product and Services
    Table 94. Duke University School of Medicine Cellular and Gene Therapy Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Duke University School of Medicine Recent Developments/Updates
    Table 96. Duke University School of Medicine Competitive Strengths & Weaknesses
    Table 97. Colorado Cord Blood Banking Basic Information, Manufacturing Base and Competitors
    Table 98. Colorado Cord Blood Banking Major Business
    Table 99. Colorado Cord Blood Banking Cellular and Gene Therapy Product Product and Services
    Table 100. Colorado Cord Blood Banking Cellular and Gene Therapy Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Colorado Cord Blood Banking Recent Developments/Updates
    Table 102. Colorado Cord Blood Banking Competitive Strengths & Weaknesses
    Table 103. MD Anderson Cancer Center Basic Information, Manufacturing Base and Competitors
    Table 104. MD Anderson Cancer Center Major Business
    Table 105. MD Anderson Cancer Center Cellular and Gene Therapy Product Product and Services
    Table 106. MD Anderson Cancer Center Cellular and Gene Therapy Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. MD Anderson Cancer Center Recent Developments/Updates
    Table 108. MD Anderson Cancer Center Competitive Strengths & Weaknesses
    Table 109. LifeSouth Community Blood Centers Basic Information, Manufacturing Base and Competitors
    Table 110. LifeSouth Community Blood Centers Major Business
    Table 111. LifeSouth Community Blood Centers Cellular and Gene Therapy Product Product and Services
    Table 112. LifeSouth Community Blood Centers Cellular and Gene Therapy Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. LifeSouth Community Blood Centers Recent Developments/Updates
    Table 114. LifeSouth Community Blood Centers Competitive Strengths & Weaknesses
    Table 115. Bloodworks Northwest Basic Information, Manufacturing Base and Competitors
    Table 116. Bloodworks Northwest Major Business
    Table 117. Bloodworks Northwest Cellular and Gene Therapy Product Product and Services
    Table 118. Bloodworks Northwest Cellular and Gene Therapy Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Bloodworks Northwest Recent Developments/Updates
    Table 120. Bloodworks Northwest Competitive Strengths & Weaknesses
    Table 121. Amgen Basic Information, Manufacturing Base and Competitors
    Table 122. Amgen Major Business
    Table 123. Amgen Cellular and Gene Therapy Product Product and Services
    Table 124. Amgen Cellular and Gene Therapy Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Amgen Recent Developments/Updates
    Table 126. Amgen Competitive Strengths & Weaknesses
    Table 127. Novartis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 128. Novartis Pharmaceuticals Major Business
    Table 129. Novartis Pharmaceuticals Cellular and Gene Therapy Product Product and Services
    Table 130. Novartis Pharmaceuticals Cellular and Gene Therapy Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. Novartis Pharmaceuticals Recent Developments/Updates
    Table 132. Novartis Pharmaceuticals Competitive Strengths & Weaknesses
    Table 133. Castle Creek Biosciences Basic Information, Manufacturing Base and Competitors
    Table 134. Castle Creek Biosciences Major Business
    Table 135. Castle Creek Biosciences Cellular and Gene Therapy Product Product and Services
    Table 136. Castle Creek Biosciences Cellular and Gene Therapy Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 137. Castle Creek Biosciences Recent Developments/Updates
    Table 138. Castle Creek Biosciences Competitive Strengths & Weaknesses
    Table 139. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 140. Spark Therapeutics Major Business
    Table 141. Spark Therapeutics Cellular and Gene Therapy Product Product and Services
    Table 142. Spark Therapeutics Cellular and Gene Therapy Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 143. Spark Therapeutics Recent Developments/Updates
    Table 144. Spark Therapeutics Competitive Strengths & Weaknesses
    Table 145. Vericel Basic Information, Manufacturing Base and Competitors
    Table 146. Vericel Major Business
    Table 147. Vericel Cellular and Gene Therapy Product Product and Services
    Table 148. Vericel Cellular and Gene Therapy Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 149. Vericel Recent Developments/Updates
    Table 150. Vericel Competitive Strengths & Weaknesses
    Table 151. Dendreon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 152. Dendreon Pharmaceuticals Major Business
    Table 153. Dendreon Pharmaceuticals Cellular and Gene Therapy Product Product and Services
    Table 154. Dendreon Pharmaceuticals Cellular and Gene Therapy Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 155. Dendreon Pharmaceuticals Recent Developments/Updates
    Table 156. Dendreon Pharmaceuticals Competitive Strengths & Weaknesses
    Table 157. Enzyvant Therapeutics GmbH Basic Information, Manufacturing Base and Competitors
    Table 158. Enzyvant Therapeutics GmbH Major Business
    Table 159. Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Product and Services
    Table 160. Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 161. Enzyvant Therapeutics GmbH Recent Developments/Updates
    Table 162. Enzyvant Therapeutics GmbH Competitive Strengths & Weaknesses
    Table 163. Mallinckrodt Basic Information, Manufacturing Base and Competitors
    Table 164. Mallinckrodt Major Business
    Table 165. Mallinckrodt Cellular and Gene Therapy Product Product and Services
    Table 166. Mallinckrodt Cellular and Gene Therapy Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 167. Mallinckrodt Recent Developments/Updates
    Table 168. Mallinckrodt Competitive Strengths & Weaknesses
    Table 169. Gilead Sciences Basic Information, Manufacturing Base and Competitors
    Table 170. Gilead Sciences Major Business
    Table 171. Gilead Sciences Cellular and Gene Therapy Product Product and Services
    Table 172. Gilead Sciences Cellular and Gene Therapy Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 173. Gilead Sciences Recent Developments/Updates
    Table 174. bluebird bio Basic Information, Manufacturing Base and Competitors
    Table 175. bluebird bio Major Business
    Table 176. bluebird bio Cellular and Gene Therapy Product Product and Services
    Table 177. bluebird bio Cellular and Gene Therapy Product Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 178. Global Key Players of Cellular and Gene Therapy Product Upstream (Raw Materials)
    Table 179. Cellular and Gene Therapy Product Typical Customers
    Table 180. Cellular and Gene Therapy Product Typical Distributors
List of Figure
    Figure 1. Cellular and Gene Therapy Product Picture
    Figure 2. World Cellular and Gene Therapy Product Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Cellular and Gene Therapy Product Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Cellular and Gene Therapy Product Production (2018-2029) & (K Units)
    Figure 5. World Cellular and Gene Therapy Product Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Cellular and Gene Therapy Product Production Value Market Share by Region (2018-2029)
    Figure 7. World Cellular and Gene Therapy Product Production Market Share by Region (2018-2029)
    Figure 8. North America Cellular and Gene Therapy Product Production (2018-2029) & (K Units)
    Figure 9. Europe Cellular and Gene Therapy Product Production (2018-2029) & (K Units)
    Figure 10. Asia-Pacific Cellular and Gene Therapy Product Production (2018-2029) & (K Units)
    Figure 11. Latin America Cellular and Gene Therapy Product Production (2018-2029) & (K Units)
    Figure 12. Middle East & Africa Cellular and Gene Therapy Product Production (2018-2029) & (K Units)
    Figure 13. Cellular and Gene Therapy Product Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Cellular and Gene Therapy Product Consumption (2018-2029) & (K Units)
    Figure 16. World Cellular and Gene Therapy Product Consumption Market Share by Region (2018-2029)
    Figure 17. United States Cellular and Gene Therapy Product Consumption (2018-2029) & (K Units)
    Figure 18. China Cellular and Gene Therapy Product Consumption (2018-2029) & (K Units)
    Figure 19. Europe Cellular and Gene Therapy Product Consumption (2018-2029) & (K Units)
    Figure 20. Japan Cellular and Gene Therapy Product Consumption (2018-2029) & (K Units)
    Figure 21. South Korea Cellular and Gene Therapy Product Consumption (2018-2029) & (K Units)
    Figure 22. ASEAN Cellular and Gene Therapy Product Consumption (2018-2029) & (K Units)
    Figure 23. India Cellular and Gene Therapy Product Consumption (2018-2029) & (K Units)
    Figure 24. Producer Shipments of Cellular and Gene Therapy Product by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Cellular and Gene Therapy Product Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Cellular and Gene Therapy Product Markets in 2022
    Figure 27. United States VS China: Cellular and Gene Therapy Product Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Cellular and Gene Therapy Product Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States VS China: Cellular and Gene Therapy Product Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 30. United States Based Manufacturers Cellular and Gene Therapy Product Production Market Share 2022
    Figure 31. China Based Manufacturers Cellular and Gene Therapy Product Production Market Share 2022
    Figure 32. Rest of World Based Manufacturers Cellular and Gene Therapy Product Production Market Share 2022
    Figure 33. World Cellular and Gene Therapy Product Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 34. World Cellular and Gene Therapy Product Production Value Market Share by Type in 2022
    Figure 35. Cellular Immunotherapies
    Figure 36. Cancer Vaccines
    Figure 37. Autologous and Allogeneic Cells
    Figure 38. World Cellular and Gene Therapy Product Production Market Share by Type (2018-2029)
    Figure 39. World Cellular and Gene Therapy Product Production Value Market Share by Type (2018-2029)
    Figure 40. World Cellular and Gene Therapy Product Average Price by Type (2018-2029) & (US$/Unit)
    Figure 41. World Cellular and Gene Therapy Product Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 42. World Cellular and Gene Therapy Product Production Value Market Share by Application in 2022
    Figure 43. Blood Cancer
    Figure 44. Prostate Cancer
    Figure 45. Skin Cancer
    Figure 46. Other
    Figure 47. World Cellular and Gene Therapy Product Production Market Share by Application (2018-2029)
    Figure 48. World Cellular and Gene Therapy Product Production Value Market Share by Application (2018-2029)
    Figure 49. World Cellular and Gene Therapy Product Average Price by Application (2018-2029) & (US$/Unit)
    Figure 50. Cellular and Gene Therapy Product Industry Chain
    Figure 51. Cellular and Gene Therapy Product Procurement Model
    Figure 52. Cellular and Gene Therapy Product Sales Model
    Figure 53. Cellular and Gene Therapy Product Sales Channels, Direct Sales, and Distribution
    Figure 54. Methodology
    Figure 55. Research Process and Data Source

Companies Mentioned

Bristol-Myers Squibb
New York Blood Center
Johnson & Johnson
Cleveland Cord Blood Center
Organogenesis
Duke University School of Medicine
Colorado Cord Blood Banking
MD Anderson Cancer Center
LifeSouth Community Blood Centers
Bloodworks Northwest
Amgen
Novartis Pharmaceuticals
Castle Creek Biosciences
Spark Therapeutics
Vericel
Dendreon Pharmaceuticals
Enzyvant Therapeutics GmbH
Mallinckrodt
Gilead Sciences
bluebird bio